spacer
home > ict > spring 2008 > raising the bar
PUBLICATIONS
International Clinical Trials

Raising the Bar

Alan Morgan of ICON Clinical Research, Europe, assesses how best to implement new standards in patient recruitment in order to achieve beneficial and effective practice

The patient recruitment methods increasingly being used by CROs involve a more scientific and targeted approach, which should become a new standard for best practice within the industry. This approach involves the use of a comprehensive in-house database covering a wide range of countries and therapeutic indications, and also includes performance data on investigators. By systematically searching the database at both a macro (country) and micro (within a specific country) level, a CRO can start the process to identify the best countries, sites and investigators in order to ensure optimum patient recruitment for a client.

The use of performance data is a major step forward in terms of how CROs operate. This approach relies on both the quality and quantity of the data in the database; it can therefore be used most effectively by larger CROs that have more extensive global and therapeutic indication coverage. Traditional feasibility studies are still required, but the focus on investigator performance can make this approach much more effective in identifying motivated investigators who have access to appropriate patients.

PREPARING THE DELIVERY STRATEGY

In order to successfully execute and deliver an effective clinical trial programme, a CRO needs to invest considerable time and effort preparing a delivery strategy prior to being awarded a contract. The most important part of this process is the initial identification of the best investigator sites in an attempt to ensure optimum patient recruitment. This process is aided by having experienced and empowered project managers in charge of patient recruitment. Other key aspects are to have contingency plans in place in order to deal with any problems or issues that may arise, and a ‘toolkit’ of tactics and approaches to enhance patient recruitment.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alan Morgan is President of ICON Clinical Research, Europe. Alan is responsible for the Phase II/IV business in the region. He joined the company in August 2006 as Vice President for Process Development. He was Global General Manager of the Phase II/IV business of MDS Pharma Services from August 2005, having joined MDS in September 2002 as General Manager of their European, Latin American and Asian Clinical Development operations. Alan’s initial career was in pharma, including seven years with Glaxo Wellcome and two years with ICI Pharmaceuticals in various business financial roles. He is a graduate of the City University Business School in London and a Fellow of the Chartered Association of Certified Accountants.
spacer
Alan Morgan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Why You Should Be Using Ultrasonic Cleaning

Natoli Engineering Company, Inc.

Clean punches and dies are essential to maintaining the integrity and efficiency of your tooling investment, as well as the quality of your product. Ultrasonic cleaning has long been considered the most effective, nondestructive way to clean tools – from medical instruments to tablet tooling. The Tableting Specification Manual (TSM) states, “An ultrasonic bath is ideal for cleaning tooling.” This high-tech cleaning process also saves time, reduces cost and is better for the environment.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement